Reinhard Marks

1.7k citations
55 papers · 793 indexed · h-index 15

Impact in

  • Hematology top 2%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
  • Oncology top 10%
    • CAR-T cell therapy research

Papers in

Reinhard Marks

51 papers receiving 783 citations

Peers

Reinhard Marks
Comparison fields: 5 of 68
  • Hematology 423
  • Oncology 301
  • Genetics 115
  • Pathology and Forensic Medicine 194
  • Immunology 179
Replace Nancy M. Hardy with:
Nancy M. Hardy United States
Nancy Boeckx Belgium
Stéphanie Nguyen France
Tony Marchand France
Eva Froňková Czechia
Don A. Stevens United States
Paul S. Martin United States
Paul G. Schlegel Germany
JH Kersey United States
Anna Mestice Italy
Reinhard Marks relative to Nancy M. Hardy United States Nancy M. Hardy's profile →
Citations per field
00.5×1.5×1.8×
Nancy M. Hardy · 1×
Citations per year

Countries citing papers authored by Reinhard Marks

Since Specialization
Citations

This map shows the geographic impact of Reinhard Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reinhard Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reinhard Marks more than expected).

Fields of papers citing papers by Reinhard Marks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reinhard Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reinhard Marks. The network helps show where Reinhard Marks may publish in the future.

Co-authors

The 25 scholars most cited alongside Reinhard Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Reinhard Marks Line = papers co-authored together Reinhard Marks links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20240
3 202312
4 20239
5 20231
6 202216
7 202113
8 202113
9 202117
10 20218
11 202014
12 20206
13 20181
14 201830
15 201562
16 201519
17 201317
18 201040
19 200753
20 20062

About Reinhard Marks

Reinhard Marks is a scholar working on Hematology, Pathology and Forensic Medicine, Genetics, Oncology and Dermatology, having authored 55 papers that have together received 793 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (22 papers), CAR-T cell therapy research (17 papers), Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (11 papers), Chronic Lymphocytic Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (9 papers), Viral-associated cancers and disorders (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). The work is most often cited by research in Hematology (423 citations), Oncology (301 citations), Genetics (115 citations), Pathology and Forensic Medicine (194 citations) and Immunology (179 citations). Reinhard Marks has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Jürgen Finke, Ralph Wäsch, Hartmut Bertz, Michael Lübbert, Rainer Claus, Björn Rüter, Gerry R. Boss, Robert Zeiser, Gabriele Ihorst and Andreas Viardot. Their work appears in journals such as Blood, Bone Marrow Transplantation, Annals of Hematology, British Journal of Haematology and Biology of Blood and Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026